Icon

ELIQUIS (nda202155)- (2.5MG,5MG)

APIXABAN BRISTOL MYERS SQUIBB
2.5MG,5MG
Yes No
2031-Feb-24 2017-Dec-28
None None
None No
ELIQUIS is a factor Xa inhibitor indicated: • to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation. • for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE), in patients who have undergone hip or knee replacement surgery. • for the treatment of DVT and PE, and for the reduction in the risk of recurrent DVT and PE following initial therapy.
8 10 1
Total Other Developers 26
Drugs with Suitability No
2.5MG ** ** Up - -
5MG ** ** Up - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** ******** ******* *********** *** *****-** & ***, *-**,**,**, ***** ********** ****, *****,, ***, *** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search





Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.